<div id="readability-page-1"><div><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/B018843D-ADE7-4CA0-A323-86EC8739F1C3/chart/price-vs-fair-value?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/B018843D-ADE7-4CA0-A323-86EC8739F1C3/chart/price-vs-fair-value"/><figcaption>NasdaqGS:MNDY 1 Year Share Price vs Fair Value</figcaption></figure><p>Explore monday.com's Fair Values from the Community and select yours</p><p> <strong>monday.com Ltd.</strong> (NASDAQ:MNDY) shareholders that were waiting for something to happen have been dealt a blow with a 39% share price drop in the last month.    Instead of being rewarded, shareholders who have already held through the last twelve months are now sitting on a 33% share price drop.   </p><p> Although its price has dipped substantially, monday.com may still be sending very bearish signals at the moment with a price-to-sales (or &#34;P/S&#34;) ratio of 8.6x, since almost half of all companies in the Software industry in the United States have P/S ratios under 4.8x and even P/S lower than 2x are not unusual.   However, the P/S might be quite high for a reason and it requires further investigation to determine if it's justified.   </p> <p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p> <p><span> Check out our latest analysis for monday.com </span></p><figure><img height="650" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/214992529-ps-multiple-vs-industry-1-dark-2/1754993638111?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1640" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/214992529-ps-multiple-vs-industry-1-dark-2/1754993638111"/><figcaption>NasdaqGS:MNDY Price to Sales Ratio vs Industry August 12th 2025</figcaption></figure><h3> What Does monday.com's P/S Mean For Shareholders? </h3><p> Recent times have been advantageous for monday.com as its revenues have been rising faster than most other companies.   It seems that many are expecting the strong revenue performance to persist, which has raised the P/S.  If not, then existing shareholders might be a little nervous about the viability of the share price.     </p><p> If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free </strong>report on monday.com. </p><h2> Is There Enough Revenue Growth Forecasted For monday.com?  </h2><p> monday.com's P/S ratio would be typical for a company that's expected to deliver very strong growth, and importantly, perform much better than the industry.  </p><p> If we review the last year of revenue growth, the company posted a terrific increase of 32%.   The latest three year period has also seen an excellent 190% overall rise in revenue, aided by its short-term performance.  So we can start by confirming that the company has done a great job of growing revenue over that time.   </p> <p> Turning to the outlook, the next three years should generate growth of 24%  each year as estimated by the analysts watching the company.  With the industry predicted to deliver 37% growth per year, the company is positioned for a weaker revenue result. </p><p> With this information, we find it concerning that monday.com is trading at a P/S higher than the industry.  Apparently many investors in the company are way more bullish than analysts indicate and aren't willing to let go of their stock at any price.  Only the boldest would assume these prices are sustainable as this level of revenue growth is likely to weigh heavily on the share price eventually.  </p> <h2> The Final Word </h2><p> A significant share price dive has done very little to deflate monday.com's very lofty P/S.      Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company. </p><p> Despite analysts forecasting some poorer-than-industry revenue growth figures for monday.com, this doesn't appear to be impacting the P/S in the slightest.  The weakness in the company's revenue estimate doesn't bode well for the elevated P/S, which could take a fall if the revenue sentiment doesn't improve.  This places shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.     </p><p> A lot of potential risks can sit within a company's balance sheet.  You can assess many of the main risks through our <strong>free</strong> balance sheet analysis for monday.com with six simple checks.  </p><p>It's important to <strong>make sure you look for a great company, not just the first idea you come across.</strong> So if growing profitability aligns with your idea of a great company, take a peek at this <strong>free</strong> list of interesting companies with strong recent earnings growth (and a low P/E).</p></div></div>

MNDY

<p>monday.com Ltd. (NASDAQ:MNDY) has experienced a significant 39% drop in share price over the past month, leading to a total decline of 33% for long-term shareholders. Despite rising revenues, the company's price-to-sales (P/S) ratio stands at 8.6x, much higher than the industry average of 4.8x. Analysts predict a 24% annual growth in revenue over the next three years, but this is below the industry forecast of 37%. The elevated P/S ratio raises concerns about the sustainability of the current share price, placing existing and potential investors at risk.</p>

Some Confidence Is Lacking In monday.com Ltd. (NASDAQ:MNDY) As Shares Slide 39%